49502-902 : Emsam 12 mg/24h Transdermal Patch


NDC49502-902
Labeler: Mylan Specialty
Product Type: Human Prescription Drug
Drug Name:  Emsam
Dosage Form: Transdermal Patch
Application #: NDA021336
Rev. Date: 


NDC Package Codes:

  • 49502-902-30: 30 POUCH IN 1 CARTON (49502‑902‑30) > 1 PATCH IN 1 POUCH (49502‑902‑01) > 24 H IN 1 PATCH

Active Ingredients:

  • Selegiline

Dosage Strength:

  • 12 mg/24h

Pharmaceutical Classes:

  • Monoamine Oxidase Inhibitor [EPC]
  • Monoamine Oxidase Inhibitors [MoA]
  • Monoamine Oxidase Type B Inhibitor [EPC]
  • Monoamine Oxidase-B Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 49502-900 Emsam 6 mg/24h Transdermal Patch by Mylan Specialty
  • 49502-901 Emsam 9 mg/24h Transdermal Patch by Mylan Specialty

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 49502-902 QR Code

< Prev: 49502-901Next: 49507-001 >

Related Discussions:

selegiline hydrochloride
5 mg capsules ## Selegiline hydrochloride is known as an MAO inhibitor used to treat Parkinson's like or Parkinson&#... 1 reply
Emsam & Contact Dermatitis
As a victim of refractory depression I have only found one medication that worked, EMSAM, unfortunately I am allergic to... 3 replies
Emsam shaking muscles
I have been taking emsam for 4 years. I guess one of the first patients. I have shaking in my muscles. I also take Ativa... 1 reply
Side effects of Emsam Patch
How long do the initial side effects of the Emsam patch last? (numbness in the hands, irritability, brain fog) ## What a... 2 replies
Looking for a doctor in Orlando, Fl who understands and prescribes EMSAM
My husband was on early trials of EMSAM (Selegiline transdermal patch) in around 2008. It was very successful in relievi...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.